Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: an Extended Follow-up Analysis
Advances in Therapy（2025）
Key words
Zanubrutinib,Orelabrutinib,Matching-adjusted indirect comparison,Progression-free survival,Relapsed or refractory mantle cell lymphoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined